Cappelletti, Chiara
Eriksson, Anna
Brorson, Ina Skaara
Leikfoss, Ingvild S.
Kråbøl, Oda
Høgestøl, Einar August
Vitelli, Valeria
Mjaavatten, Olav
Harbo, Hanne F.
Berven, Frode
Bos, Steffan D.
Berge, Tone http://orcid.org/0000-0002-5297-2034
Funding for this research was provided by:
Helse Sør-Øst RHF (2017114, 240102)
Oslo Metropolitan University
Biogen Idec Norway
Sanofi-Genzyme Norway
Odd Fellow Society Norway
Halvor Høies fund
Norges Forskningsråd (295910)
Article History
Received: 3 September 2021
Accepted: 22 June 2022
First Online: 5 July 2022
Declarations
:
: The Regional Committee for Medical and Health Research Ethics South East, Norway approved the study. Written informed consent was obtained from all study participants.
: TB received unrestricted research grants from Biogen Idec and Sanofi-Genzyme, EAH received honoraria for lecturing and advisory board activity from Biogen, Merck and Sanofi-Genzyme and unrestricted research grant from Merck, ISL received unrestricted research grant from Novartis and HFH has received travel support, honoraria for advice or lecturing from Biogen, Merck, Sanofi-Genzyme, Roche and an unrestricted research grant form Merck. The other authors declare that they have no competing interests.